We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Illinois-based drugmaker Horizon Pharma has acquired the U.S. rights to AstraZeneca’s Vimovo delayed-release tablets in order to bolster the company’s primary care portfolio. Rights outside the U.S. will be retained by AstraZeneca. Read More
A much-talked-about re-adjudication of GlaxoSmithKline's controversial RECORD trial of Avandia reaffirms its original findings that the drug does not boost cardiovascular risk, the company says. Read More
As it continues to face congressional calls for more action on drug shortages, the FDA Wednesday said it is allowing imports of injectables used in total parenteral nutrition (TPN). Read More